“We are very pleased that Anoro Ellipta, the latest combination medicine to be developed as a result of our partnership with GSK, is now available in the US,” said Rick E Winningham, CEO of Theravance. “We believe this product will add to the choice of treatment options available to healthcare physicians when considering how to help meet the needs of their patients.”
Full US Prescribing Information for Anoro Ellipta, including Boxed Warning and Medication Guide, is available at
- See more at: http://www.rtmagazine.com/2014/04/anoro-ellipta-available-in-us-treatment-copd/#sthash.ZrizZvh7.dpuf